ClinicalTrialsFinder

Lymphoid Hematological Malignancies Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies

Lymphoid Hematological MalignanciesRelapsed and Refractory
He Huang100 enrolled1 locationNCT04283006